Relmada Therapeutics Inc (RLMD)
0.3614
-0.02
(-4.79%)
USD |
NASDAQ |
Dec 24, 16:00
Relmada Therapeutics Price: 0.3614 for Dec. 24, 2024
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
Eli Lilly and Co | 795.67 |
Sensei Biotherapeutics Inc | 0.4541 |
NovaBay Pharmaceuticals Inc | 0.5399 |
Palatin Technologies Inc | 0.99 |
iBio Inc | 2.415 |
Price Related Metrics
PEG Ratio | -0.101 |
Price to Book Value | 0.229 |
Earnings Yield | -791.4% |
Market Cap | 10.90M |
PEGY Ratio | -0.101 |